Insurance Coverage & Financial Assistance

Exact Sciences is committed to supporting patient access to the Oncotype MAP Pan-Cancer Tissue test to help you in making informed decisions about your treatment.

Financial Responsibility Information

Out-of-pocket costs for the Oncotype MAP Pan-Cancer Tissue test, if any, are determined by the insurance company. You may have financial responsibility for a co-pay, co-insurance, deductible or non-covered charges as determined by your insurance plan once available appeal options are completed.

 
92% of Oncotype MAP Pan-Cancer Tissue test patients have $0 financial responsibility*
This calculation includes patients with Medicare, Medicare Advantage, Medicaid, Managed Medicaid and commercial insurance and includes the cost of both NGS and IHC components as most commonly ordered by providers. Patient cost-sharing amounts, including deductibles and copays will vary by plan and coverage type. Only your patient’s insurer can confirm if and how the Oncotype MAP Pan-Cancer Tissue test will be covered.
97% of Oncotype MAP Pan-Cancer Tissue test patients have a financial responsibility of less than $100*
This calculation includes patients with Medicare, Medicare Advantage, Medicaid, Managed Medicaid and commercial insurance and includes the cost of both NGS and IHC components as most commonly ordered by providers. Patients with high-deductible plans may receive a bill for most or all the cost of the Oncotype MAP Pan-Cancer Tissue test if they have not satisfied their deductible. 

* The numbers cited are based on historical patient billing data from updated dates. Rates of coverage vary by state and region. Exceptions for coverage may apply. Exact Sciences strongly encourages patients to contact their insurer with questions about Oncotype MAP Pan-Cancer Tissue test coverage.

Genomic Access Program

Exact Sciences believes that everyone should have access to the information they need to make confident, informed decisions about their cancer treatments. To ensure you can focus on your health, Exact Sciences created the Genomic Access Program (GAP), which helps you determine payment options for our tests. We work with providers, patients, and insurance companies to investigate coverage and complete any prior authorization requirements, where applicable.

If you have insurance, Exact Sciences* will bill your insurance once testing is complete. In the event your insurance denies payment, Exact Sciences may contact you to complete a consent form that allows us to pursue an appeal on your behalf. If you don’t have insurance, our Customer Service team is available to help you manage the cost of testing.

Download the GAP Brochure
Download in other languages: Spanish | Traditional Chinese | Simplified Chinese

To discuss our flexible payment options, your extenuating financial circumstances, or to be pre-screened for financial assistance, contact Customer Service by phone at 888-ONCOTYPE (888-662-6897, option 2).

*Genomic Health, Inc., a wholly-owned subsidiary of Exact Sciences Corporation is the billing entity for Oncotype tests.

Financial assistance

Exact Sciences offers financial assistance for eligible patients based on the Federal poverty guidelines. If eligible, both insured and uninsured patients will have no out-of-pocket costs.

 

For more information, see our FAQs.

Making cancer care smarter.™